Regenxbio (RGNX) Misses Q1 EPS by 38c, Misses on Revenue
Tweet
Share
E-mailGet Alerts RGNX Hot Sheet
Join SI Premium – FREE
Regenxbio (NASDAQ: RGNX) reported Q1 EPS of ($1.72), $0.38 worse than the analyst estimate of ($1.34). Revenue for the quarter came in at $6.39 million versus the consensus estimate of $25.8 million.
For earnings history and earnings-related data on Regenxbio (RGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The LGL Group (LGL) Misses Q2 EPS by 8c
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Trump threatens to bomb Oman over Iran stance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
